Sign in

CIK 0001501697

  • Non-accelerated filer
  • Smaller reporting company

X4 Pharmaceuticals, Inc

Sign in to watch
Ticker
XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273181608
Phone
+1 857-529-8300
Business address
61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
Former names
Arsanis, Inc.
Open-market buys, last 90 days
$11,884
in 1 filing
Open-market sales, last 90 days
$33,658
in 1 filing

Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. KIRSKE DAVID −$34K Chief Financial Officer sold 7% of stake
  2. Craig Adam R +$12K Executive Chairman 1 filing
Date Insider Transaction Shares Price Value Owned after
2017-11-20 ORBIMED ADVISORS LLC 10% owner Conversion +328,909 600,672
2017-11-20 ORBIMED ADVISORS LLC 10% owner Conversion +114,320 714,992
2017-11-20 ORBIMED ADVISORS LLC 10% owner Conversion +653,974 1,368,966
2017-11-20 ORBIMED ADVISORS LLC 10% owner Conversion +500,000 $10.00 $5.0M 1,868,966
2017-11-20 ORBIMED ADVISORS LLC 10% owner Conversion · Series A-1 Convertible Preferred Stock −66,667 0
2017-11-20 ORBIMED ADVISORS LLC 10% owner Conversion · Series A-2 Convertible Preferred Stock −704,846 0
2017-11-20 ORBIMED ADVISORS LLC 10% owner Conversion · Series B Convertible Preferred Stock −736,648 0
2017-11-20 ORBIMED ADVISORS LLC 10% owner Conversion · Series C Convertible Preferred Stock −229,412 0
2017-11-20 ORBIMED ADVISORS LLC 10% owner Conversion · Series D Convertible Preferred Stock −2,232,014 0
2017-11-20 GORDON CARL L Director Conversion +19,533 19,533
2017-11-20 GORDON CARL L Director Conversion +252,230 271,763
2017-11-20 GORDON CARL L Director Conversion +328,909 600,672
2017-11-20 GORDON CARL L Director Conversion +114,320 714,992
2017-11-20 GORDON CARL L Director Conversion +653,974 1,368,966
2017-11-20 GORDON CARL L Director Purchase +500,000 $10.00 $5.0M 1,868,966
2017-11-20 GORDON CARL L Director Conversion · Series A-1 Convertible Preferred Stock −66,667 0
2017-11-20 GORDON CARL L Director Conversion · Series A-2 Convertible Preferred Stock −704,846 0
2017-11-20 GORDON CARL L Director Conversion · Series B Convertible Preferred Stock −736,648 0
2017-11-20 GORDON CARL L Director Conversion · Series C Convertible Preferred Stock −229,412 0
2017-11-20 GORDON CARL L Director Conversion · Series D Convertible Preferred Stock −2,232,014 0

Page 20 of 25 · 490 trades